Evidence map›Paper›PMID 19202432›Full record

ReviewTransplantation2009

Hematopoietic cell transplantation for tolerance induction: animal models to clinical trials.

Megan Sykes

Open access · greenAbstract readReview
In one paragraph

Review in Transplantation, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Hematopoietic stem cells and solid organ transplantation.Transplantation reviews (Orlando, Fla.) · 2016
    Review
  9. Article
  10. Myeloid-lymphoid ontogeny in the rhesus monkey (Macaca mulatta).Anatomical record (Hoboken, N.J. : 2007) · 2014
    Article
  11. Article
  12. Article
  13. Review
  14. CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.Journal of molecular cell biology · 2012
    Review
  15. Article
  16. Clinical transplantation tolerance.Seminars in immunopathology · 2011
    Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Megan SykesBone Marrow Transplantation Section, Transplantation Biology Research Center, Surgical Service, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02129, USA. megan.sykes@tbrc.mgh.harvard.edu
Harvard University · US

Funding

XENOGRAFT TOLERANCE THROUGH MIXED CHIMERISMP01AI045897 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Megan Sykes · 2000 to 2026
$71.9M
XENOGENIC TOLERANCE IN MICEP01HL018646 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI MADSEN, JOREN C · 1985 to 2019
$37.5M
STATISTICAL COREP01CA111519 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PREFFER, FREDERIC IRA · 2006 to 2010
$9.3M
MIXED CHIMERISM AS AN APPROACH TO TRANSPLANT TOLERANCER01HL049915 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SYKES, MEGAN · 1993 to 2010
$3.9M
SEPARATION OF GVH AND GVL IN MOUSE MODELSR01CA079989 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SYKES, MEGAN · 2000 to 2008
$2.2M
IMMUNE TOLERANCE NETWORK-266015416-266015416N01AI015416 · NIAID · REGENTS OF THE UNIVERSITY OF C · PI BLUESTONE, JEFFREY A · 2002 to 2006
–
NCI NIH HHS P01 CA111519NCI NIH HHS R01 CA079989NHLBI NIH HHS P01 HL018646NHLBI NIH HHS R01 HL049915NIAID NIH HHS N01 AI015416NIAID NIH HHS P01 AI045897
6 · The paper itself

Abstract

The induction of donor-specific immune tolerance is the "holy grail" of transplantation, as it would avoid the toxicities of chronic immunosuppressive therapies while preventing acute and chronic graft rejection. A large number of approaches to tolerance induction have been described in the experimental literature, but only hematopoietic cell transplantation has shown preliminary success for intentional tolerance induction in pilot clinical trials. This review summarizes the conditions that allow progress to be made in moving strategies for tolerance induction from the bench to the bedside and discuss the mechanisms by which tolerance may be achieved through hematopoietic cell transplantation.

Indexed as

Immune ToleranceAnimalsClinical Trials as TopicGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHistocompatibility TestingHLA AntigensHumansModels, AnimalTransplantation, HomologousHLA Antigens

Identifiers

PMID19202432
PMCPMC2723946
OpenAlexW2056602603

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.